Skip to content
Menu

OptimizeRx Corporation OPRX

Full chart Compare
Set alert

Price alert · OPRX

All alert types
7.34 USD -1.53 (-17.25%)

At closeNov 13, 2026, 4:20 PM EST

7.34 0.00 0.00%

After hours · Nov 13, 4:20 PM ET

7.23 Day range 8.69
4.54 52-week range 15.59
YTD
-40.13%
1 year
-52.52%

OPRX revenue history

Revenue is income from the company’s ordinary business activities.

109,429,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2009: 26,723USDFY 2010: 71,065USDFY 2011: 1,111,520USDFY 2012: 1,989,086USDFY 2013: 4,679,741USDFY 2014: 6,502,962USDFY 2015: 7,220,678USDFY 2016: 7,751,462USDFY 2017: 12,127,422USDFY 2018: 21,206,363USDFY 2019: 24,598,274USDFY 2020: 43,313,323USDFY 2021: 61,292,598USDFY 2022: 62,450,156USDFY 2023: 71,522,000USDFY 2024: 92,127,000USDFY 2025: 109,429,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-31109,429,00017,302,00018.78%
FY 20242024-12-3192,127,00020,605,00028.81%
FY 20232023-12-3171,522,0009,071,84414.53%
FY 20222022-12-3162,450,1561,157,5581.89%
FY 20212021-12-3161,292,59817,979,27541.51%
FY 20202020-12-3143,313,32318,715,04976.08%
FY 20192019-12-3124,598,2743,391,91115.99%
FY 20182018-12-3121,206,3639,078,94174.86%
FY 20172017-12-3112,127,4224,375,96056.45%
FY 20162016-12-317,751,462530,7847.35%
FY 20152015-12-317,220,678717,71611.04%
FY 20142014-12-316,502,9621,823,22138.96%
FY 20132013-12-314,679,7412,690,655135.27%
FY 20122012-12-311,989,086877,56678.95%
FY 20112011-12-311,111,5201,040,4551464.09%
FY 20102010-12-3171,06544,342165.93%
FY 20092009-12-3126,723Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:40.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.